{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:03:43Z","timestamp":1790240623537,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clml.2020.02.008","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T20:02:39Z","timestamp":1582142559000},"page":"533-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET\u2013CT-documented First Remission"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-8783","authenticated-orcid":false,"given":"Gordon","family":"Glober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Milgrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinda Rao","family":"Korivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-8961","authenticated-orcid":false,"given":"Corey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus A.","family":"Wagner-Bartak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8299","authenticated-orcid":false,"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-3629","authenticated-orcid":false,"given":"Raphael","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrit","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alma","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Nastoupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina S.","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3982-3664","authenticated-orcid":false,"given":"Chelsea C.","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.02.008_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2011.557455","article-title":"Current concepts and controversies in the management of early stage Hodgkin lymphoma","volume":"52","author":"Maeda","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.02.008_bib2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","article-title":"Hodgkin\u2019s lymphoma in adults","volume":"380","author":"Townsend","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.02.008_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PPO.0b013e3181a282d8","article-title":"Clinical manifestations and natural history of Hodgkin\u2019s lymphoma","volume":"15","author":"Connors","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.clml.2020.02.008_bib4","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2013.49.8246","article-title":"Relapsed Hodgkin lymphoma in older patients: a comprehensive analysis from the German Hodgkin Study Group","volume":"31","author":"Boll","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1182\/blood-2011-10-388058","article-title":"Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma","volume":"119","author":"Moskowitz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.008_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.seminoncol.2018.01.008","article-title":"Post-treatment surveillance imaging in lymphoma","volume":"44","author":"Hiniker","year":"2017","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood-2016-08-685073","article-title":"Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma","volume":"129","author":"Cohen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.008_bib8","unstructured":"National Comprehensive Cancer Network. Treatment Guide: Classical Hodgkin lymphoma Follow-up Care (Version 2.2019). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkins.pdf. Accessed: December 12, 2019."},{"key":"10.1016\/j.clml.2020.02.008_bib9","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00277-009-0752-4","article-title":"Role of 18FDG-PET\/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma","volume":"88","author":"Crocchiolo","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.02.008_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3324\/haematol.2011.056010","article-title":"Positron emission tomography\/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs","volume":"97","author":"El-Galaly","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.02.008_bib12","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1002\/cncr.25240","article-title":"Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis","volume":"116","author":"Lee","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.02.008_bib13","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1093\/annonc\/mdu181","article-title":"Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Eichenauer","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.6004\/jnccn.2012.0061","article-title":"Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines","volume":"10","author":"Hoppe","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2020.02.008_bib15","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.02.008_bib17","series-title":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2","year":"2006"},{"key":"10.1016\/j.clml.2020.02.008_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejrad.2014.02.015","article-title":"Estimated radiation exposure and cancer risk from CT and PET\/CT scans in patients with lymphoma","volume":"83","author":"Guttikonda","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clml.2020.02.008_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.clml.2020.02.008_bib20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cncr.28698","article-title":"Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission","volume":"120","author":"Pingali","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.02.008_bib21","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3109\/10428194.2013.767902","article-title":"Computed tomography and positron emission tomography\/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective","volume":"54","author":"Patel","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.02.008_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.6004\/jnccn.2011.0048","article-title":"Role of routine imaging in lymphoma","volume":"9","author":"Wagner-Johnston","year":"2011","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2020.02.008_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bjh.12687","article-title":"Hodgkin lymphoma patients in first remission: routine positron emission tomography\/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass","volume":"164","author":"Dann","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.02.008_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1148\/radiol.2441060810","article-title":"Hodgkin disease: diagnostic value of FDG PET\/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?","volume":"244","author":"Schaefer","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.clml.2020.02.008_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jacr.2014.07.038","article-title":"ACR appropriateness criteria follow-up of Hodgkin lymphoma","volume":"11","author":"Ha","year":"2014","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.clml.2020.02.008_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andre","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib27","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.02.008_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/10428194.2017.1361032","article-title":"Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility","volume":"59","author":"Guidot","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.02.008_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/asheducation-2014.1.481","article-title":"Optimal disease surveillance strategies in non-Hodgkin lymphoma","volume":"2014","author":"Cohen","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2020.02.008_bib31","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.29277","article-title":"Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy","volume":"121","author":"Gandikota","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.02.008_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hon.2676","article-title":"Whole body magnetic resonance imaging (WB-MRI) in lymphoma: state of the art","volume":"38","author":"Albano","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2020.02.008_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1148\/radiol.14132154","article-title":"Advanced-stage Hodgkin lymphoma: US\/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures","volume":"272","author":"Picardi","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.clml.2020.02.008_bib34","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.008_bib35","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2217\/fon.15.92","article-title":"Next-generation surveillance strategies for patients with lymphoma","volume":"11","author":"Cohen","year":"2015","journal-title":"Future Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:11Z","timestamp":1761870851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020300884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2152265020300884"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET\u2013CT-documented First Remission","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}